The MTA at 8

J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1120-1122. doi: 10.1097/CHI.0b013e3181bac557.

Authors

Tobias Banaschewski¹, Jan Buitelaar², David R Coghill³, Joseph A Sergeant⁴, Edmund Sonuga-Barke⁵, Alessandro Zuddas⁶, Eric Taylor⁷; ADHD European Guidelines Group

Affiliations

¹ Central Institute of Mental Health, Mannheim, Germany.
² University Medical Center St. Radboud Nijmegen, The Netherlands.
³ University of Dundee Dundee, United Kingdom.
⁴ Faculty of Psychology and Education Vrije Universitat Amsterdam.
⁵ University of Southampton Southampton, United Kingdom University of Ghent Ghent, Belgium.
⁶ University of Cagliari Cagliari, Italy.
⁷ Kings College London, London.

PMID: 19855221
DOI: 10.1097/CHI.0b013e3181bac557

No abstract available

Publication types

Comment
Comparative Study
Letter

MeSH terms

Adrenergic Uptake Inhibitors / therapeutic use*
Atomoxetine Hydrochloride
Attention Deficit Disorder with Hyperactivity / therapy*
Behavior Therapy*
Central Nervous System Stimulants / therapeutic use*
Child
Combined Modality Therapy
Follow-Up Studies
Humans
Long-Term Care
Multicenter Studies as Topic
Propylamines / therapeutic use*
Randomized Controlled Trials as Topic
Social Environment
Treatment Outcome

Substances

Adrenergic Uptake Inhibitors
Central Nervous System Stimulants
Propylamines
Atomoxetine Hydrochloride